ZENITH TX2 THORACIC ENDOVASCULAR GRAFT
FDA premarket approval P070016/S007 · decided 2013-05-20
Approval details
- PMA number
- P070016
- Supplement
- S007
- Supplement type
- Special (Immediate Track)
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- ZENITH TX2 THORACIC ENDOVASCULAR GRAFT
- Generic name
- SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
- Applicant
- William Cook Europe Aps
- Date received
- 2013-04-23
- Decision date
- 2013-05-20
- Days to decision
- 27 days
- Decision code
- APPR
- Product code
- MIH
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Bjaeverskov
- Statement
- APPROVAL FOR UPDATING SEVERAL SECTIONS IN THE IFU REGARDING MAINTAINING HEMOSTASIS, TRIGGER WIRE RELEASE, AND MRI SAFETY INFORMATION.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.